cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Tg Therapeutics Inc
9 own
19 watching
Current Price
$14.63
$0.48
(3.39%)
logo-tgtx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
2,126.59M
52-Week High
52-Week High
14.85
52-Week Low
52-Week Low
3.48
Average Volume
Average Volume
4M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization2,126.59M
icon52-Week High14.85
icon52-Week Low3.48
iconAverage Volume4M
iconDividend Yield--
iconP/E Ratio--
What does the Tg Therapeutics Inc do?
TG Therapeutics, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases primarily in the United States. It develops TG-1101 (ublituximab), a chimeric, glycoengineered monoclonal antibody that targets an epitope on the CD20 antigen found on the surface of B-lymphocytes developed to aid in the depletion of circulating B-cells; and TG-1101 in combination with TGR-1202 for relapsed/refractory non-Hodgkin's lymphoma and chronic lymphocytic leukemia. The company also develops TGR-1202, an orally available phosphoinositide-3-kinase delta inhibitor with nanomolar potency to the delta isoform and high selectivity over the alpha, beta, and gamma isoforms, as well as for hematologic malignancies. In addition, it develops a pre-clinical program to develop interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors; bromodomain and extra terminal (BET) inhibitor program in the field of hematological malignancies; and anti-PD-L1 and anti-GITR antibody research programs that are in pre-clinical development stage in the field of hematological malignancies. The company has license agreements with LFB Biotechnologies S.A.S, GTC Biotherapeutics, LFB/GTC LLC, and Ildong Pharmaceutical Co. Ltd. for the development and commercialization of TG-1101 (ublituximab); Rhizen Pharmaceuticals, SA for the development and commercialization of TGR-1202; Ligand Pharmaceuticals Incorporated for the development and commercialization of IRAK4 inhibitor technology; Checkpoint Therapeutics, Inc. for the development and commercialization of anti-PD-L1 and anti-GITR antibody research programs; and Jubilant Biosys for the development and commercialization of BET inhibitor program. TG Therapeutics, Inc. is headquartered in New York, New York.
Read More
How much money does Tg Therapeutics Inc make?
News & Events about Tg Therapeutics Inc.
Ticker Report
1day ago
TG Therapeutics (NASDAQ:TGTX Get Rating) had its price objective raised by Evercore ISI from $16.00 to $25.00 in a research note published on Tuesday, Benzinga reports. Evercore ISI currently has an outperform rating on the biopharmaceutical companys stock. Several other research ...
Globe Newswire
2days ago
NEW YORK, Jan. 26, 2023 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the commercial launch of BRIUMVI (ublituximab-xiiy), for the treatment of relapsing forms of multiple sclerosis (RMS), to include clinically isolated syndrome, relapsing-remitting disease, and active ...
Globe Newswire
22days ago
Presentation scheduled for Monday, January 9, 2023 at 9:45 AM PTNEW YORK, Jan. 06, 2023 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Companys Chairman and Chief Executive Officer, will present at the 41st Annual J.P. Morgan Healthcare Conference...
PR Newswire
29days ago
Thinking about buying stock in Palisade Bio, Kala Pharmaceuticals, F-Star Therapeutics, Nuwellis, or TG Therapeutics? Thinking about buying stock in Palisade Bio, Kala Pharmaceuticals, F-Star Therapeutics, Nuwellis, or TG Therapeutics? PR Newswire NEW YORK, Dec. 30, 2022 NEW YORK, Dec. 30, 2022...
Frequently Asked Questions
Frequently Asked Questions
What is Tg Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Tg Therapeutics Inc shares?
plus_minus_icon
How can I buy Tg Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Tg Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Tg Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Tg Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Tg Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Tg Therapeutics Inc?
plus_minus_icon
What percentage is Tg Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Tg Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$14.63
$0.48
(3.39%)
logo-tgtx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00